SubHero Banner
Text

April 2023

Core topics in this month’s edition include:

  • Makena (hydroxyprogesterone caproate) – withdrawal of FDA approval
  • Vowst (fecal microbiota spores, live-brpk) – new orphan drug approval
  • Recall of various Akorn drug products

Download PDF

Text